Posterior Urethral Valves Flashcards
What is the most common cause of lower urinary tract obstruction?
Posterior urethral valves (PUVs) are the most common cause of lower urinary tract obstruction (LUTO) in boys, with an incidence of 1 in 5000–8000 male births.
Although the majority of boys with PUV are diagnosed antenatally, approximately one-third will be diagnosed during childhood or adolescence.
Once diagnosed and surgically treated, PUV requires lifelong follow-up since it is the most common cause of LUTO leading to end-stage renal disease (ESRD) in children.
H&A
What is the embryology of posterior urethral valves?
5 - 6 weeks AOG:
At 5–6 weeks gestational age (GA), the orifice of the mesonephric duct migrates from an anterolateral position in the cloaca to Müller’s tubercle on the posterior wall of the urogenital sinus, occurring simultaneously with division of the cloaca.
Remnants of the mesonephric duct normally remain as small, distinct, paired lateral folds termed the inferior urethral crest and plicae colliculi.
When the insertion of the mesonephric ducts into the cloaca is too anterior, normal migration of the ducts is impeded, and the ducts fuse anteriorly, resulting in abnormal ridges, which become the PUV.
A smaller aperture between the leaflets causes more obstruction than those with a larger aperture and a less prominent anterior component.
H&A
What are the types of PUV?
Three distinct types of PUV have been described.
Type I is an obstructing membrane that radiates distally and anteriorly from the verumontanum toward the membranous urethra, fusing in the midline.
Approximately 95% of PUV are type I, in which the valves are thought to be a single membranous structure with the opening positioned posteriorly near the verumontanum.
Type III appears as a membranous diaphragm with a central opening at the verumontanum.
The obstructing tissue also has been termed a congenital obstructing posterior urethral membrane.
It is thought that instrumentation with a urethral catheter might disrupt the posterior aspect of the membrane, resulting in the appearance of a type I valve.
Type II valves are prominent longitudinal folds of hypertrophied smooth muscle that radiate cranially from the verumontanum to the posterolateral bladder neck, but these are nonobstructive and clinically insignificant.
H&A
What antenatal ultrasound findings point to PUV?
About 10% of antenatally diagnosed obstructive uropathy is due to PUV, and about two-thirds are diagnosed antenatally.
It has been known for two decades that the gestational age (GA) at which hydronephrosis is detected influences prognosis.
Typical antenatal ultrasound (US) findings include bilateral hydroureteronephrosis, a distended bladder, and a dilated prostatic urethra, called a “keyhole” sign.
Discrete focal cysts in the renal parenchyma are diagnostic of renal dysplasia.
Fetal megacystis is defined after the first trimester as a sagittal dimension (in mm) greater than the GA (in weeks).
Amniotic fluid volume (AFV) is variable.
Other diagnoses that may have antenatal US findings similar to those of PUV include prune-belly syndrome, urethral atresia or stenosis, and bilateral high-grade vesicoureteral reflux (VUR).
US parameters alone are not able to predict postnatal renal function.
H&A
Which antenatal ultrasound findings for PUV are associated with compromised lung development?
Oligohydramnios observed in the second trimester suggests significant obstructive uropathy and portends a poor prognosis.
Fetal obstructive uropathy is known to affect lung development.
Metanephric urine production begins at 12 weeks, but the fetal contribution to amniotic fluid begins after 18 weeks.
Normal AFV is essential to bronchial branching in the lung, especially during the critical canalicular phase between 16 and 28 weeks.
Therefore, oligohydramnios is associated with pulmonary hypoplasia and an arrest of normal lung development, resulting in an abnormally low number or size of bronchopulmonary segments or alveoli.
In the fetus with suspected PUV and normal amniotic fluid volume, serial fetal sonograms are necessary to monitor the status of the hydronephrosis and AFV.
If oligohydramnios develops, bladder drainage may help restore the amniotic fluid and allow normal pulmonary development.
Before any intervention, a karyotype should be obtained to confirm the male gender and to detect chromosomal abnormalities, which occur in about 12%.
Fetal renal function can be assessed with serial urinary electrolytes and β2 -microglobulin levels.
Normally, fetal urine is
hypotonic (favorable prognosis), with a sodium <100 mEq/L,
chloride <90 mEq/L,
osmolality <200 mEq/L, and
β2 -microglobulin levels <6 mg/L between 18 and 30 weeks GA.
Elevated fetal urine electrolytes and β2 -microglobulin levels are an indication of irreversible renal dysfunction.
Sequential bladder aspiration every 48–72 hours should be performed because the initial urine sample may be stagnant and fresh urine more accurately reflects the function of the fetal kidneys.
Previous observations have suggested that if the fetal urine is hypotonic, and oligohydramnios is present, then fetal intervention to restore the AFV should be considered, with the goal of preventing pulmonary hypoplasia.
This procedure has been performed in the first trimester although the majority of fetuses are diagnosed and treated in the second trimester.
The problem with fetal intervention in managing LUTO is that not only is the diagnosis not definitive but also the severity of the obstruction is often variable, and the effect of the obstruction is dependent upon the GA at onset and whether the resulting renal dysplasia or cystic dysplasia is unilateral or bilateral.
In theory, though, diverting the urine into the amniotic fluid with a percutaneously placed vesicoamniotic shunt (VAS) should decompress the urinary tract, but it does not allow the bladder to cycle.
Therefore, when counseling expectant parents, they need to understand that their newborn may have limited renal function or ESRD, even if the drainage procedure is successful.
In addition, VAS can have complications in up to 45% including herniation of the omentum or bowel through the fetal abdominal wall.
Also, these shunts can become obstructed or displaced, necessitating additional procedures that increase morbidity to the mother and fetus with a 5% procedure-related fetal loss.
Despite advances in technology, fetal intervention has not significantly impacted on the development of ESRD.
However, perinatal intervention has reduced perinatal mortality by ameliorating oligohydramnios at the critical time of lung development between 16 and 28 weeks of gestation.
H&A
What is the clinical presentation of PUV?
Neonates with PUV not diagnosed prenatally can present with symptoms of delayed voiding or a reduced urinary stream.
Also, respiratory distress secondary to pulmonary hypoplasia may be the primary manifestation of PUV.
Other postnatal signs and symptoms include an abdominal mass (49%), failure to thrive (10%), lethargy, poor feeding, urosepsis (8%), and urinary ascites (7%).
On physical examination in the newborn, a palpable walnut-sized bladder secondary to the hypertrophic detrusor muscle is found.
Urinary ascites can result in significant abdominal distention.
Older boys can have persistent diurnal incontinence or abdominal distention.
H&A
What imaging should be requested to diagnose PUV postnatally?
Significant bilateral hydroureteronephrosis and a thickwalled, distended bladder are seen on US.
Corticomedullary differentiation is a favorable prognostic sign regarding renal function.
Conversely, echogenic kidneys or subcortical cysts and the loss of corticomedullary differentiation are unfavorable signs.
Suprapubic or perineal US may demonstrate a dilated prostatic urethra, which is pathognomonic for PUV.
The voiding cystourethrogram (VCUG) is the only radiographic study that definitively establishes the diagnosis of PUV.
The valves appear as a defined lucency in the distal prostatic urethra.
The posterior urethra is dilated and elongated.
The bladder is trabeculated with cellules and diverticuli, and bladder neck hypertrophy is seen.
Unilateral VUR is present in 25% and bilateral VUR in 25% of infants with PUV.
Renal nuclear scintigraphy with a technetium-99mlabeled dimercaptosuccinic acid (99m Tc-DMSA) is performed if imaging studies show thin or abnormal parenchyma in either kidney on US and/or high-grade VUR. The study should be delayed until 6–8 weeks of age to allow maturation of renal function. This study is effective in establishing baseline differential renal function. However, if renal function is poor, visualization of the kidneys will be suboptimal.
An alternative to renal scintigraphy is dynamic contrast-enhanced magnetic resonance urography (MRU). This study provides high-resolution renal images and assessment of differential renal function, but requires an anesthetic.
H&A
What is the initial management for PUV?
The initial treatment of neonates may focus not only on bladder decompression but also on any degree of respiratory distress that may require immediate pulmonary resuscitation with endotracheal intubation and positive-pressure ventilation.
If urinary ascites is present, paracentesis may be necessary to correct the fluid and electrolyte imbalance and/or improve ventilation.
The bladder can be decompressed with a 5 or 8 French feeding tube.
The catheter can be difficult to pass due to significant dilation of the prostatic urethra and hypertrophy of the bladder neck as well as the valvular obstruction.
The catheter often tends to coil in the prostatic urethra, and a Coudé tip catheter may be helpful. US can confirm placement of the catheter within the bladder.
Insertion of a urinary catheter is discouraged because the inflated balloon can obstruct the ureteral orifices when the thick-walled bladder is decompressed, and can cause bladder spasms, which further obstruct the intramural ureters.
Penna and colleagues have described the use of a 6 French 12 cm Double-J stent for decompression of the bladder postnatally. They found that a 5 French feeding tube and a 6 French Foley catheter drain more slowly than the Double-J due to their diminished cross-sectional luminal area.
Amoxicillin or cephalexin prophylaxis should be started.
Electrolytes, blood urea nitrogen (BUN), creatinine, and fluid status are monitored carefully.
The serum creatinine concentration at birth reflects maternal renal function and should gradually decrease to 0.3–0.4 mg/ dL when there is favorable renal function.
However, when there is compromised renal function, the creatinine will remain the same or increase, even after bladder decompression.
Metabolic acidosis and hyperkalemia can occur if renal function is impaired.
Consultation with a pediatric nephrologist is invaluable because metabolic abnormalities due to renal insufficiency and ESRD lead to somatic growth abnormalities requiring long-term monitoring.
H&A
What are the indications for primary valve ablation in PUV?
Endoscopic valve ablation is performed after the neonate is clinically stable, and the serum creatinine has decreased to a normal value or to a lower level showing no further change.
Well-lubricated infant urethral sounds can be passed to gently dilate the meatus and glandular urethra.
The neonatal male urethra usually accepts a 9.5 French endoscope.
Overly aggressive dilation of the urethra in order to pass a larger endoscope may lead to urethral trauma with subsequent stricture formation, and should be avoided.
Vigorous dilation may also result in iatrogenic hypospadias due to splitting of the glans to the subcoronal level.
An 8 French or 9.5 French cystoscope typically is used with a 3 French Bugbee electrode inserted through the operating channel.
Alternatively, the 9 French resectoscope can be used with a 180° curved electrode.
The valve leaflets should be incised using a low cutting current at the 5 and 7 o’clock positions. Incision at the 12 o’clock position, where the valve leaflets fuse is also performed.
Although the use of the neodymium:YAG laser ablation has been reported, an alternative technique employs the holmium:YAG laser at 10 and 2 o’clock that may result in fewer complications than transurethral ablation using diathermy current.
If urethral bleeding develops, coagulation should be performed carefully because injury to the urethra or ejaculatory ducts can occur with overzealous cautery.
Following valve ablation, a pediatric feeding tube is left for 1–2 days.
A VCUG can be performed at the time of planned feeding tube removal. If not, the VCUG and renal US should be obtained 2–4 weeks after ablation to confirm satisfactory valve disruption and assess the upper urinary tracts and bladder emptying.
In addition, renal function should be monitored carefully.
Valve ablation is successful in >90% of patients.
The most common complication is incomplete valve ablation in which case repeat cystoscopy and valve incision is necessary.
Urethral stricture is uncommon if small endoscopes are used and cautery is avoided.
H&A
When is temporary urinary diversion indicated for PUV?
An alternative to primary valve ablation is cutaneous vesicostomy.
This approach is appropriate in a small or premature neonate when the pediatric cystoscope is too large for the urethra.
It is also advisable to use this approach if severe hydroureteronephrosis, urinary ascites, or highgrade VUR with poor renal function are present.
In these cases, upper urinary tract drainage is necessary to maintain existing renal function.
The most popular technique was originally described by Blocksom and popularized by Duckett. A small transverse incision is performed midway between the umbilicus and pubic symphysis, and the dome of the bladder is brought to the skin. The vesicostomy should calibrate to 24–26 French to avoid stenosis. Daily dilation of the stoma with a plastic medicine dropper helps prevent stomal contraction.
Complications include stomal stenosis and prolapse, if the anterior wall of the bladder is exteriorized rather than the bladder dome.
Valve ablation should not be performed at the time of vesicostomy because the urethra will remain “dry” and stricture is likely.
A vesicostomy allows the bladder to cycle and grow at low pressures, and does not reduce bladder capacity.
These neonates should be maintained on antibiotic prophylaxis.
In the past, after insertion of a urinary catheter into the bladder, proximal diversion with cutaneous pyelostomy or cutaneous ureterostomy was advocated for neonates and infants with severe hydronephrosis and a persistently elevated creatinine. Theoretically, proximal diversion provides better renal drainage than a vesicostomy, particularly with ureterovesical obstruction, and optimizes the potential for renal function and somatic growth. However, proximal drainage has not been shown to prevent ESRD because ≥85% of these patients have renal dysplasia.
In addition, by diverting the urine away from the bladder, regular cyclical bladder filling and contraction does not occur, which results in a smaller, less compliant bladder.
Currently, proximal diversion is reserved for the rare case in which the primary surgical intervention, valve ablation, or vesicostomy fails to improve upper tract drainage.
When needed, the preferred method of proximal diversion is the Sober-en-T ureterostomy in which the proximal ureter is divided and exteriorized on the abdominal wall.
The proximal end of the distal ureteral segment is then anastomosed to the renal pelvis.
The advantage of this form of diversion is that it allows urine to drain into the bladder, thereby maintaining bladder cycling, while providing good upper tract drainage.
Rupture of the renal fornix with urinary extravasation and transudation into the peritoneum occurs in 5–15% of neonates with PUV.
Some infants develop a perirenal urinoma, whereas others have urinary ascites.
The differential renal function of kidneys with urinoma vs. those without is similar. However, with urinary ascites, significant electrolyte abnormalities can result from urinary reabsorption, and respiratory compromise can also occur from the abdominal distention.
Evaluation for extravasation begins with US, VCUG, and renal scintigraphy. The early uptake phase of a99m TcMAG3 renal scan often demonstrates which kidney is involved. Inserting a 5 French or 8 French feeding tube into the bladder may decompress the bladder and upper urinary tract sufficiently to permit the fornix to seal. Percutaneous drainage is needed if the extravasation and the serum creatinine continue to increase.
In addition, respiratory compromise, infection, hypertension, or significant parenchymal compression is also an indication for percutaneous drainage.
If extravasation persists, insertion of a percutaneous nephrostomy often solves the problem.
Unfortunately, with forniceal extravasation, typically the renal pelvis is decompressed, making it difficult to insert the nephrostomy tube. In these cases, a drain can be placed into the urinoma. Rarely is open exploration needed.
H&A
How is follow up done after initial surgical intervention for PUV?
Antibiotic prophylaxis is continued until the upper tract dilation improves, which may take several years if VUR persists.
Most infants benefit from combined urologic and nephrologic care starting at birth.
Common clinical problems include significant polyuria secondary to an inability of the kidneys to concentrate urine, metabolic acidosis (which may affect bone/somatic growth and overall health), renal insufficiency with hypocalcemia and hyperphosphatemia, and hypertension.
Sarhan et al. found that renal function predicts vitamin D and parathyroid hormone levels, so treatment should be aimed at managing the chronic renal disease and controlling vitamin D deficiency and hyperparathyroidism.
If the patient remains clinically well with good somatic growth, periodic follow-up with US, electrolyte measurements, BUN and creatinine, urinalysis, and blood pressure evaluations will ensure satisfactory growth and development.
Early treatment with anticholinergic therapy (oxybutynin) may also be beneficial. In a nonrandomized study of infants with PUV, treatment with oxybutynin for 2 years resulted in significant reduction in high voiding pressures and a significant improvement in bladder capacity.
H&A
How is the prognosis of PUV patients evaluated?
The prognosis for satisfactory renal function can be predicted from several factors.
A serum creatinine concentration <0.8 mg/dL 1 month after initial treatment or at age 1 year has been associated with favorable long-term renal function.
Nadir creatinine defined as the lowest creatinine during the first year after diagnosis has been used as a common prognostic indicator of renal outcomes in boys with PUV.
Coleman et al. reported the nadir creatinine in 96 boys with a mean follow-up of 9.4 years.
They found that nadir creatinine was highly predictive of chronic renal insufficiency (CRI) as well as ESRD.
They concluded that a nadir creatinine >0.85 mg/dL was associated with a high risk of CRI and a nadir <0.4 mg/dL was low risk. Those boys with a nadir creatinine between these values had intermediate risk. In their study population, using the low-, intermediate-, and high-risk stratification, 5.3%, 28.3%, and 100%, respectively, developed CRI.
In another recent study, Coleman proposed the use of creatinine velocity (CV) as an additional important prognostic factor.
CV is defined as the slope of the rise or fall of the serum creatinine during the first 5 days following bladder decompression.
The slope of the line is the rate of change of serum creatinine mmol/L per day.
The authors reviewed 62 boys with PUV who were assessed during their first month of life, with 9.4 years follow-up.
When the CV was greater than 3 mmol/L per day (rising creatinine) and nadir creatinine was 0.93 + 0.15 mg/dL, there was a higher risk of progression to CRI. In this study, 10/16 with a rising creatinine developed chronic kidney disease (CKD). They concluded that the CV and nadir creatinine together may be a better prognostic indicator than nadir creatinine alone.
Visualization of the corticomedullary junction differentiation on renal US is also associated with a favorable outcome. This radiologic finding may not be present on the initial US, but may become apparent during the first few months of life.
Achieving diurnal continence by the age of 5 years indicates that minimal or no bladder dysfunction is present and is also a favorable finding.
Another prognostic feature that has been thought to be favorable is the presence of a pressure pop-off mechanism such as massive VUR into a nonfunctioning kidney (termed the VURD syndrome: valves, unilateral reflux, dysplasia), urinary ascites, or a large bladder diverticulum.
The concept is that the high intravesical pressure is dissipated, allowing more normal renal development.
Although short-term studies have suggested that these mechanisms allow more normal renal development, at age 8–10 years, only 30% of boys with the VURD syndrome have a normal serum creatinine.
Hoag et al. studied 89 patients, of whom 26% had VURD. Assessment of renal impairment was performed at 77 months for the VURD group and 57 months for the nonVURD group. There was no significant difference in longterm renal outcome in either group. Nadir creatinine and patient age at diagnosis were important predictors of renal function in this study.
In other studies, the most significant prognostic factor for the future development of CKD is the GFR at 1 year of age, and the development of proteinuria portends a worse prognosis.
Adverse prognostic factors include bilateral VUR, persistence of the serum creatinine higher than 1.0 mg/dL after initial therapy, identification of small subcapsular renal cysts (indicative of renal dysplasia), increased renal echogenicity, and loss of corticomedullary differentiation (CMD).
In addition, failure to achieve diurnal continence is an indication of bladder instability and detrusor sphincter dyssynergia (DSD), which can result in elevated upper urinary tract pressures and a gradual deterioration in renal function.
A retrospective study in 2011 of 260 boys with PUV from 1992–2008 showed risk factors for progression to ESRD included nadir serum creatinine >1.0 mg/dL, bilateral grade III or higher reflux at diagnosis, recurrent febrile urinary tract infections (UTIs), and severe bladder dysfunction.
About 10% of these boys progressed to ESRD at a mean age of 11 years (range 5–16 years).
Nadir serum creatinine and bladder dysfunction were found to be independent risk factors predictive of ultimate progression to ESRD.
Another adverse prognostic finding is a renal parenchymal area <12 cm2 on the first postnatal renal US, especially when the nadir serum Cr is 0.8–1.1 mg/dL.
A more recent study by Odeh et al. also used estimates of total renal parenchymal quantity and quality using renal echogenicity and CMD on initial postnatal US as prognosticators in determining risk of ESRD with valves.
In this study, mean parenchymal area was 16 cm2 in patients with ESRD versus 21.41 cm2 in patients without ESRD, the mean CMD was 1.77 and 1.21 in patients with and without ESRD, respectively.
Bilateral echogenic kidneys were highly predictive of ESRD as was CMD.
A low CMD index was associated with creatinine >0.8 mg/dL at 1 year and with bilateral echogenic kidneys at presentation.
Other adverse predictive factors include prenatal diagnosis, younger gestational age, oligohydramnios, renal cortical cysts, and echogenic kidneys.
Bilgutay and colleagues studied risk factors for progression to renal failure. 62 Of the 104 boys with PUV, 20.2% developed at least stage IIIA CKD, with 8.6% progressing to ESRD.
Nadir creatinine was the only independent risk factor for poor renal function.
H&A
Is the late diagnosis of PUV more benign than earlier diagnosed PUV?
Although late presentation of PUV has been thought to be a more benign entity, studies over the past two decades have shown that this may not be true.
A recent study evaluated the impact of the timing of diagnosis on long-term outcome in 52 patients with PUV who were diagnosed between 1994 and 2008. Thirty-nine boys were diagnosed by 1 year of age, and 13 were diagnosed after 1 year.
There was no statistical difference between groups in the rate of ESRD at a mean of 7.2 years following valve ablation.
In the early diagnosis group, 10% required renal transplant, while no patient in the late diagnosis group developed ESRD, suggesting a lower risk of long-term renal insufficiency.
Chronic renal failure (CRF) occurred in 52% with early diagnosis who had abnormal renal parenchyma while CRF developed in 33% in the late diagnosis group who had normal appearing kidneys.
A retrospective review was performed on 141 boys with PUV that presented after birth. Most (90%) patients were born after 1990 and were diagnosed at a mean age of 46 months. Five of the 12 had chronic disease at initial presentation without improvement following treatment, and 7 of 12 developed CKD 5–23 years after diagnosis.
Disease progression was associated with bilateral hydronephrosis, increased severity of hydronephrosis, and bilateral VUR.
Sarhan et al. performed a retrospective study between 1990 and 2010 of 144 diagnosed prenatally and 171 diagnosed postnatally. Of the 96 (30%) patients who developed CKD, 27 (19%) were prenatally diagnosed and 69 (40%) were diagnosed postnatally. The nadir serum creatinine levels of these groups were 0.6 and 0.8 mg/dL, respectively, and the mean final serum creatinine was 0.9 and 1.7 mg/dL, respectively. The most common late presentation was urinary retention in 92/171 patients (53%). This study suggests that prenatal screening and diagnosis may reduce the incidence of CKD in these children.
H&A
What are indications for vesicostomy closure in PUV patients?
In those boys requiring early vesicostomy, the decision to close the vesicostomy should be made carefully.
If febrile UTIs are noted with the vesicostomy, closure may be helpful because it will reduce the risk of bacterial contamination of the urinary tract.
In other patients, closure should be performed prior to renal transplantation.
In most cases, vesicostomy closure is performed after the upper urinary tracts have stabilized and the child is large enough to undergo simultaneous valve ablation, generally between ages 1 and 3 years.
Preoperatively, a cystogram using a Foley catheter, introduced via the vesicostomy with the balloon inflated to avoid leakage of contrast, is performed to assess whether significant VUR is present and to evaluate the appearance of the bladder.
If significant VUR is seen and the child is quite young, it is usually safe to close the vesicostomy at the time of valve ablation and delay reflux correction of the VUR until the child is older and the bladder is larger.
Anticholinergic medication is helpful as long as the bladder is emptying.
Following closure of the vesicostomy, the upper tracts should be monitored for worsening hydronephrosis, incomplete bladder emptying, and a significant change in serum creatinine.
H&A
How should vesicoureteral reflux be managed in PUV patients?
At the initial presentation of PUV, VUR is present in approximately 50% of boys. Half of these boys will have bilateral VUR and half unilateral.
After valve ablation, nearly all patients will show improvement in reflux grade at one year.
Another 25% will develop spontaneous VUR.
However, in these patients, VUR may not resolve for as long as 3 years after initial treatment, and resolution of high-grade VUR is unlikely.
Antibiotic prophylaxis is continued, and periodic upper tract imaging and cystography should be performed.
Renal deterioration without infection may be a sign of bladder dysfunction. Lower tract evaluation with videourodynamics is important.
VUR should be corrected if breakthrough infections occur or if it remains high grade.
The efficacy of endoscopic subureteric injection therapy has not been proved, but its use remains an option.
Most pediatric urologists are adept at performing ureteral reimplantation, but reimplanting thick, dilated ureters into the abnormal bladder can be challenging. A 15-30% complication rate has been reported, most often persistent reflux or ureteral obstruction.
Recently, a technique using a distal ureteral split-cuff nipple with a long ureteral trough within the detrusor has been performed with a psoas hitch and/or a transureteroureterostomy when needed. Hydronephrosis was improved in two-thirds of the 45 megaureters in one study.
If bilateral high-grade VUR is found, a transureteroureterostomy can be performed in conjunction with a single, long, tapered reimplant and a psoas hitch. However, if the single reimplanted ureter becomes obstructed, the upper tracts may deteriorate rapidly.
If unilateral high-grade reflux into a kidney with reasonable function occurs, transureteroureterostomy into the nonrefluxing ureter is an option.
In boys with unilateral VUR into a dysplastic kidney, a nephrectomy should be considered at some point. The ureter should be removed unless the bladder is small and/ or poorly compliant. In this case, ureterocystoplasty is an option.
Postoperatively, the remaining kidney should be monitored carefully for the development of hydronephrosis because the pressure “pop-off” mechanism has been removed and it may have had a beneficial effect.
H&A
What are the causes of urinary incontinence in boys with PUV?
As many as 50% of boys with PUV have ongoing daytime incontinence into late childhood.
Significant urodynamic abnormalities (55%) may persist following relief of the bladder outlet obstruction.
Several potential causes for urinary incontinence are known in boys with PUV and include the following:
- Detrusor abnormalities such as
(a) an overactive bladder secondary to uninhibited detrusor contractions,
(b) overflow incontinence,
(c) poor compliance, and
(d) myogenic failure - High-pressure voiding secondary to incomplete valve ablation
- Detrusor sphincter discoordination in which the sphincter muscle fails to relax during bladder contraction and incomplete emptying
- Polyuria secondary to a concentrating defect as a result of long-standing obstructive uropathy that causes renal tubular damage
- Valve bladder, which is a bladder with poor compliance resulting from fibrosis secondary to long-standing obstruction. This clinical situation can cause secondary ureteral obstruction with worsening hydronephrosis if the bladder pressure is >35cmH2O.
Consequently, long-term therapy for the boy with PUV includes management of the bladder including overnight drainage as well as attention to renal function.
H&A
What is the long-term risk of ESRD in PUV patients?
Heikkilä et al. from Finland reported outcomes in 193/200 males with PUV from 1953–2003.
With a median age of 31 years (range 6–69 years), 22.8% (44/193) had progressed to ESRD.
The lifetime risk of ESRD in this cohort was 28.5%.
The time to progression to ESRD correlated with the lowest serum creatinine value during the first postoperative year.
Of the 44 patients progressing to ESRD, 30 (68%) progressed to ESRD before age 17 years.
At the time of the report, 59 (31%) patients were older than 34 and did not have ESRD.
An increased risk of ESRD was associated with early presentation, pneumothorax, bilateral VUR, and recurrent UTI following valve ablation.
No patient progressed to ESRD after their mid-30s.
With improved neonatal care and management of CKD in newborns, it is likely that the risk of ESRD will decrease.
H&A
What factors affect outcomes of renal
transplantation among PUV patients?
According to the report from CRI registry of the North American Pediatric Renal Trials and Collaborative Studies database, 11,186 pediatric patients underwent renal transplantation in 2014 in the United States and 15.3% had a history of congenital obstructive uropathy.
In many cases, impaired renal function can be stabilized during childhood.
However, during adolescence, there may be insufficient renal reserve, and dialysis or renal transplantation becomes necessary.
Retrospective studies of boys with PUV undergoing renal transplantation have suggested that the valve bladder may have a detrimental effect on graft survival.
If that bladder function is addressed prior to renal transplantation, recent studies have shown no difference in graft survival or serum creatinine levels between boys with PUV and children with nonobstructive causes of renal failure.
These results may reflect more effective treatment of the valve bladder recently.
It has been postulated that recurrent urinary tract infections in the face of immunosuppression will have a negative impact on graft function and survival.
Lopez Pereira et al. studied 36 patients with a history of PUV undergoing renal transplantation, 12 of whom had undergone augmentation cystoplasty, and all of whom were on the same immunosuppressive regimen.
Although the incidence of urinary tract infection was significantly higher in the augmented group, the 10-year graft survival was 100% in the augmented group and 84.8% in the controls, showing that augmentation cystoplasty did not negatively affect graft survival.
H&A
What is the effect of PUV on adult sexual function and fertility?
Few long-term studies have evaluated the reproductive status of men who were born with PUV.
Theoretically, prostate function might be affected because of elevated urethral pressure during embryonic development and ongoing voiding dysfunction.
In addition, some boys with PUV have reflux into the seminal vesicles and ejaculatory ducts as well as a history of cryptorchidism, which might contribute to impaired fertility.
In another recent report from Finland, sexual function was assessed using the International Index of Erectile Function.
There were 67 men with PUV and 102 age-matched controls with a mean age of 38 years in both groups.
Increasing age was the only risk factor for developing erectile dysfunction. Only 1 of 61 (2%) sexually active men could not ejaculate. In this series, there was no increase in ejaculatory problems in those men who had undergone both PUV ablation and bladder neck incision, which was commonly performed several decades ago.
Almost half the men had children and four of seven with a renal transplant had children. Paternity rates were similar to the general Finnish population. Eight (12%) men had attempted to father children without success.
In another Finnish study, 68 men with PUV and 272 controls with a median age of 38.5 years responded to the Danish Prostatic Symptom Score.
The prevalence of lower urinary tract symptoms (LUTS), including mild hesitancy, weak stream, incomplete bladder emptying, and straining, was increased about twofold in PUV men when compared with controls.
Most of the study group reported little to no LUTS.
Infrequently, pyospermia and reduced sperm counts were noted in men with a history of PUV and severe LUTS.
Azoospermia was uncommon, but when observed, it was usually associated with CRF.
Another study of 16 men treated for PUV in infancy reported that sexual function and voiding symptoms were normal, and their semen analysis was adequate for fertility.
H&A
Which of the following is not a variety of continent urinary diversion?
A. Kock pouch.
B. Indiana pouch.
C. Mainz pouch.
D. Mitrofanoff stoma.
E. End ureterostomy.
E
End ureterostomy is a variety of incontinent diversion.
Other incontinent diversions are vesicostomy, nephrostomy, loop ureterostomy, ileal pouch and colonic conduit.
Syed/MCQ
—
Urinary diversion can be either incontinent or continent.
With incontinent diversion the reservoir is external to the body (ostomy bag or diaper in children) and is emptied routinely when full.
With continent urinary diversion the urinary reservoir is routinely emptied by clean intermittent catheterization (CIC).
Classically when the reservoir has been made entirely of gastrointestinal segments, it has been known as a continent urinary diversion (CUR).
In children, the primary diagnoses requiring urinary reconstruction are spinal dysraphism, exstrophy, posterior urethral valves, or complex cloacal anomalies.
In these disorders, the diseased native bladder can be incorporated into the reconstruction so that true CURs are rare in children. However, most will require intestinocystoplasty and a catheterizable abdominal wall channel and therefore they are “continent reservoirs” and are considered as such in this chapter.
Historically permanent incontinent urinary diversion was used to protect the kidneys from the deleterious effects of increased bladder and renal storage pressures or to manage urinary incontinence.
In more contemporary practice, medical management of bladder dysfunction with CIC and anticholinergic agents has limited the indications for surgical intervention.
Urodynamic expertise has allowed identification and aggressive management of the high-risk patients.
The development of surgical techniques to allow storage of urine at safe pressures has virtually eliminated the use of permanent forms of incontinent urinary diversion, but this still remains an appropriate option for some patients.
Temporary diversion is still required for select patients but is rarely first-line management for the bladder or the upper urinary tract.
Coran
Which of the following is true related to posterior urethral valve?
A. Type I is straight oriented diaphragm.
B. Type II is most common.
C. It inhibits detrusor atrophy.
D. Proximal urethra is shortened and dilated.
E. Bladder neck is secondarily narrowed.
E
Bladder neck is secondarily narrowed.
Type I posterior urethral valve is most common and is obliquely oriented obstructing diaphragm. It exhibits detrusor hypertrophy.
Proximal urethra is elongated and dilated.
Syed/MCQ
Features of posterior urethral valve include all except:
A. Thin-walled bladder on in-utero ultrasound.
B. Infant with thin stream.
C. Retention of urine.
D. Incontinence of urine.
E. Hypertension
A
Antenatal ultrasound shows thick-walled trabeculated bladder with or without
Hydroureteronephrosis.
Newborn may present with thin stream, cry during micturition, retain urine, and may have palpable bladder/palpable kidney.
Infants and children may also present as failure to thrive, recurrent UTI, incontinence, dribbling of urine, anaemia and hypertension.
Syed/MCQ